-
1
-
-
0001492161
-
Male hormone stimulation is prerequisite and an incitant in common baldness
-
Hamilton J.B. Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat. 71:1942;451-480.
-
(1942)
Am J Anat
, vol.71
, pp. 451-480
-
-
Hamilton, J.B.1
-
2
-
-
0026521725
-
The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women
-
Rushton D.H., Ramsay I.D. The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women. Clin Endocrinol (Oxf). 36:1992;421-427.
-
(1992)
Clin Endocrinol (Oxf)
, vol.36
, pp. 421-427
-
-
Rushton, D.H.1
Ramsay, I.D.2
-
3
-
-
0025037581
-
Testosterone at high concentrations interacts with the androgen receptor similarly to dihydrotestosterone
-
Grino P.B., Griffin J.E., Wilson J.D. Testosterone at high concentrations interacts with the androgen receptor similarly to dihydrotestosterone. Endocrinology. 126:1990;1165-1172.
-
(1990)
Endocrinology
, vol.126
, pp. 1165-1172
-
-
Grino, P.B.1
Griffin, J.E.2
Wilson, J.D.3
-
4
-
-
0030610903
-
Different levels of 5a-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia
-
Sawaya M.E., Price V.H. Different levels of 5a-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol. 109:1997;296-300.
-
(1997)
J Invest Dermatol
, vol.109
, pp. 296-300
-
-
Sawaya, M.E.1
Price, V.H.2
-
5
-
-
0032834918
-
Diffuse female hair loss: Are androgens necessary?
-
Orme S., Cullen D.R., Messenger A.G. Diffuse female hair loss: are androgens necessary? Br J Dermatol. 141:1999;521-523.
-
(1999)
Br J Dermatol
, vol.141
, pp. 521-523
-
-
Orme, S.1
Cullen, D.R.2
Messenger, A.G.3
-
6
-
-
0031683562
-
Finasteride in the treatment of men with androgenetic alopecia
-
Kaufman K.D., Olsen E.A., Whiting D.et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 39:1998;578-589.
-
(1998)
J Am Acad Dermatol
, vol.39
, pp. 578-589
-
-
Kaufman, K.D.1
Olsen, E.A.2
Whiting, D.3
-
7
-
-
0032836486
-
Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss
-
Roberts J.L., Fiedler V., Imperato-McGinley J.et al. Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol. 41:1999;555-563.
-
(1999)
J Am Acad Dermatol
, vol.41
, pp. 555-563
-
-
Roberts, J.L.1
Fiedler, V.2
Imperato-McGinley, J.3
-
9
-
-
0032722225
-
Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment
-
Price V.H., Menefee E., Strauss P.C. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. J Am Acad Dermatol. 41:1999;717-721.
-
(1999)
J Am Acad Dermatol
, vol.41
, pp. 717-721
-
-
Price, V.H.1
Menefee, E.2
Strauss, P.C.3
-
10
-
-
0033523961
-
Transgender induction of hair follicles
-
Reynolds A.J., Lawrence C., Cserhalmi-Friedman P.B., Christiano A.M., Jahoda C.A.B. Transgender induction of hair follicles. Nature. 402:1999;33-34.
-
(1999)
Nature
, vol.402
, pp. 33-34
-
-
Reynolds, A.J.1
Lawrence, C.2
Cserhalmi-Friedman, P.B.3
Christiano, A.M.4
Jahoda, C.A.B.5
|